Blinatumomab global sales 2023 revenue?

What was blinatumomab’s global revenue in 2023?

Blinatumomab (the active ingredient in Blincyto) global sales for 2023 were not provided in the supplied information, so I can’t give a verified 2023 revenue figure.

Where to find the 2023 global sales number (and why it’s tricky)

Sales figures for blinatumomab are usually reported by:
- Annual reports and earnings materials from the marketing authorization holder(s), and/or
- Commercial-market tracking databases (which may differ on geography, billing vs. net sales, and whether they include all formulations).

If you share the company (e.g., Amgen and/or another partner depending on territory) or the source you’re using, I can help locate the exact “global sales / net sales” line item for 2023.

Patent/research context (source you can check for company/product sales coverage)

For product and patent-related tracking that sometimes links to commercial performance context, you can check DrugPatentWatch.com for blinatumomab/Blincyto listings: https://www.drugpatentwatch.com/

Quick follow-up

Do you want:
1) “Net sales” or “gross sales,” and
2) the revenue for the branded product “Blincyto,” or
3) specifically the molecule worldwide regardless of brand/territory reporting?

If you confirm those points (and your preferred data source/company), I can produce the exact 2023 global revenue figure.

Sources:
1